Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort (Q30416480)

14 August 2017

Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort (English)

1 reference

14 August 2017

hepatocellular carcinoma

1 reference

L M Kulik

1

1 reference

14 August 2017

R A Fisher

2

1 reference

14 August 2017

D R Rodrigo

3

1 reference

14 August 2017

R S Brown

4

1 reference

14 August 2017

C E Freise

5

1 reference

14 August 2017

A Shaked

6

1 reference

14 August 2017

J E Everhart

7

1 reference

14 August 2017

G T Everson

8

1 reference

14 August 2017

J C Hong

9

1 reference

14 August 2017

P H Hayashi

10

1 reference

14 August 2017

C L Berg

11

1 reference

14 August 2017

A S F Lok

12

1 reference

14 August 2017

A2ALL Study Group

13

1 reference

14 August 2017

language of work or name

English

0 references

publication date

20 September 2012

1 reference

American Journal of Transplantation

14 August 2017

1 reference

14 August 2017

12

1 reference

14 August 2017

11

1 reference

14 August 2017

2997-3007

1 reference

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Growth of hepatocellular carcinoma in the regenerating liver

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Relative risk estimated from the ratio of two median unbiased estimates

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Living donor liver transplantation for hepatocellular carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523685

Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.

20 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Hepatocellular carcinoma: Ablate and wait versus rapid transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04272.X

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium

1 reference

12 December 2020

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

12 December 2020

A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies

1 reference

12 December 2020

Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion

1 reference

12 December 2020

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival

1 reference

12 December 2020

Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series

1 reference

12 December 2020

Extending indication: role of living donor liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma

1 reference

12 December 2020

Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma

1 reference

12 December 2020

10.1111/J.1600-6143.2012.04272.X

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22994906

1 reference